Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin

Details for Australian Patent Application No. 2004260543 (hide)

International Classifications

Event Publications

7 April 2005 Application Open to Public Inspection

Published as AU-A-2004260543

7 April 2005 PCT application entered the National Phase

30 March 2006 Amendment Made

The nature of the amendment is: Amend the priority details to 2003273297

18 December 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the Name Warren Pharmaceuticals, Inc. and Kenneth S. Warren Institute, Inc., Application No. 2004260543, under INID (43), correct the date to 24 March 2005 Corrigenda

2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.